Lineage Cell Therapeutics
Price & Volume
Stats
See more52W Range | $0.36-$2.09 |
Market Cap | $400.7M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $10.8M |
Revenue Growth (YoY) | -2.6% |
Gross Profit (12 Mos) | -$1.9M |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • 12 days ago
Lineage extends cash runway into Q2 2027 as OpRegen site expansion accelerates and new partnerships advance pipeline
Yahoo Finance • 2 months ago
Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial
Yahoo Finance • 3 months ago
Lineage Cell Revenue Doubles in Q2
Yahoo Finance • 3 months ago
Lineage signals expanded diversification strategy following OpRegen milestones and $42.3M cash position
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
CFO | Ms. Jill Ann Howe |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
